BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1190 related articles for article (PubMed ID: 33953163)

  • 21. Characterization of periostin isoform pattern in non-small cell lung cancer.
    Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
    Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.
    Lin C; Majoor CJ; Roelofs JJ; de Kruif MD; Horlings HM; Borensztajn K; Spek CA
    BMC Cancer; 2017 Feb; 17(1):113. PubMed ID: 28173772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
    Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
    Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-microenvironment interactions studied by zonal transcriptional profiling of squamous cell lung carcinoma.
    Wu H; Haag D; Muley T; Warth A; Zapatka M; Toedt G; Pscherer A; Hahn M; Rieker RJ; Wachter DL; Meister M; Schnabel P; Müller-Decker K; Rogers MA; Hoffmann H; Lichter P
    Genes Chromosomes Cancer; 2013 Mar; 52(3):250-64. PubMed ID: 23074073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer.
    Chammaa M; Malysa A; Redondo C; Jang H; Chen W; Bepler G; Fernandez-Valdivia R
    J Cell Physiol; 2018 Dec; 233(12):9548-9562. PubMed ID: 29953591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.
    Andriani F; Bertolini G; Facchinetti F; Baldoli E; Moro M; Casalini P; Caserini R; Milione M; Leone G; Pelosi G; Pastorino U; Sozzi G; Roz L
    Mol Oncol; 2016 Feb; 10(2):253-71. PubMed ID: 26514616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.
    Zhou D; Xie M; He B; Gao Y; Yu Q; He B; Chen Q
    Mol Med Rep; 2017 Oct; 16(4):5129-5136. PubMed ID: 28849055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy.
    Nitschkowski D; Marwitz S; Kotanidou SA; Reck M; Kugler C; Rabe KF; Ammerpohl O; Goldmann T
    Clin Epigenetics; 2019 Nov; 11(1):157. PubMed ID: 31718698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
    Tan D; Deeb G; Wang J; Slocum HK; Winston J; Wiseman S; Beck A; Sait S; Anderson T; Nwogu C; Ramnath N; Loewen G
    Diagn Mol Pathol; 2003 Dec; 12(4):201-11. PubMed ID: 14639106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
    Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
    Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer.
    Lv M; Xu Y; Tang R; Ren J; Shen S; Chen Y; Liu B; Hou Y; Wang T
    Mol Cancer Ther; 2014 Dec; 13(12):3152-62. PubMed ID: 25349304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
    Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
    Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
    Castañón E; Soltermann A; López I; Román M; Ecay M; Collantes M; Redrado M; Baraibar I; López-Picazo JM; Rolfo C; Vidal-Vanaclocha F; Raez L; Weder W; Calvo A; Gil-Bazo I
    Cancer Lett; 2017 Aug; 402():43-51. PubMed ID: 28549790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer.
    Yoshimura K; Inoue Y; Tsuchiya K; Karayama M; Yamada H; Iwashita Y; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Lung Cancer; 2020 Mar; 141():21-31. PubMed ID: 31931443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment.
    Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G
    J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capture-Based Targeted Ultradeep Sequencing in Paired Tissue and Plasma Samples Demonstrates Differential Subclonal ctDNA-Releasing Capability in Advanced Lung Cancer.
    Mao X; Zhang Z; Zheng X; Xie F; Duan F; Jiang L; Chuai S; Han-Zhang H; Han B; Sun J
    J Thorac Oncol; 2017 Apr; 12(4):663-672. PubMed ID: 28007624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.